TRACE
Trace a source
tape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advicetape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advice
publisheddirectional thesisLONGyoutubenot an explicit trade

LLY directional thesis

MFN drug pricing crushes US branded prices but volume access (Ozempic/Mounjaro at $149) and tariff relief reset pharma economics.

$1,087entry snapshot
pendingcurrent snapshot
— pendingsince mention
“The result is Ozempic and Mounjaro are on Medicaid and Medicare for $149 instead of not on it.”
48:56claim_id mcl_662f6790c30e8e651fopen evidence ↗
Classification directional thesis

Human-reviewed public claim.

Evidence span 48:56

Evidence URL, source timestamp, and excerpt are attached to this permanent claim page.

Correction path available

Creators or reviewers can request reclassification, context, or entity corrections without erasing the source record.

Machine-readable claim
{
  "version": "market-claims.v1",
  "claim": {
    "id": "mcl_662f6790c30e8e651f",
    "url": "/trace/claims/mcl_662f6790c30e8e651f",
    "status": "PUBLISHED",
    "claimType": "DIRECTIONAL_THESIS",
    "direction": "LONG",
    "claimText": "MFN drug pricing crushes US branded prices but volume access (Ozempic/Mounjaro at $149) and tariff relief reset pharma economics.",
    "confidence": 0.72,
    "expert": {
      "slug": "allin",
      "displayName": "All-In Podcast",
      "kind": "PERSON",
      "status": "UNCLAIMED",
      "avatarUrl": "/api/avatars/acfd1290-a",
      "url": "/trace/experts/allin",
      "claimed": false
    },
    "primaryEntity": {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "LLY",
      "name": "LLY",
      "exchange": null,
      "confidence": 0.78
    },
    "evidence": {
      "evidenceUrl": "https://www.youtube.com/watch?v=fd6QaEJOjvI&t=2936s",
      "sourceUrl": "https://youtube.com/watch?v=fd6QaEJOjvI",
      "timecode": "48:56",
      "startMs": 2936000,
      "endMs": null,
      "excerpt": "The result is Ozempic and Mounjaro are on Medicaid and Medicare for $149 instead of not on it."
    },
    "performance": {
      "entryPrice": 1086.6484035663,
      "currentPrice": null,
      "returnPct": null,
      "relativePct": null,
      "method": "PASTE_AUTHOR_PRICE"
    },
    "resolutionStatus": "OPEN",
    "ambiguityNotes": null,
    "horizon": "multi-year",
    "isExplicitTrade": false,
    "notFinancialAdvice": true,
    "disclaimer": "AISO tracks public statements, not verified portfolio positions. This is not financial advice."
  },
  "expert": {
    "slug": "allin",
    "displayName": "All-In Podcast",
    "kind": "PERSON",
    "status": "UNCLAIMED",
    "avatarUrl": "/api/avatars/acfd1290-a",
    "url": "/trace/experts/allin",
    "claimed": false
  },
  "source": {
    "platform": "YOUTUBE",
    "title": "Howard Lutnick: How America Can Hit 6% GDP Growth in 2026",
    "sourceUrl": "https://youtube.com/watch?v=fd6QaEJOjvI",
    "publishedAt": "2026-01-09T01:18:50.000Z"
  },
  "evidence": {
    "evidenceUrl": "https://www.youtube.com/watch?v=fd6QaEJOjvI&t=2936s",
    "sourceUrl": "https://youtube.com/watch?v=fd6QaEJOjvI",
    "timecode": "48:56",
    "startMs": 2936000,
    "endMs": null,
    "excerpt": "The result is Ozempic and Mounjaro are on Medicaid and Medicare for $149 instead of not on it.",
    "quote": "The result is Ozempic and Mounjaro are on Medicaid and Medicare for $149 instead of not on it.",
    "speaker": "Howard Lutnick"
  },
  "entities": [
    {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "LLY",
      "name": "LLY",
      "exchange": null,
      "confidence": 0.78
    }
  ],
  "marketData": {
    "entry": {
      "price": 1086.6484035663,
      "currency": "USD",
      "observedAt": "2026-01-09T01:18:50.000Z",
      "method": "PASTE_AUTHOR_PRICE"
    },
    "current": null,
    "returnPct": null
  },
  "snapshots": [
    {
      "kind": "ENTRY",
      "symbol": "LLY",
      "assetClass": "EQUITY",
      "price": 1086.6484035663,
      "probability": null,
      "currency": "USD",
      "provider": "paste.trade",
      "providerSymbol": "xyz:LLY",
      "observedAt": "2026-01-09T01:18:50.000Z",
      "method": "PASTE_AUTHOR_PRICE",
      "returnPct": null,
      "relativePct": null
    }
  ]
}

AISO Market Calls classifies public statements from public sources. A classification such as long thesis, short thesis, or explicit call describes the content of the public statement and does not prove that the speaker actually entered, exited, or held a position. Market performance shown is calculated from public market data around the source publication or timestamp. It is not investment advice.